ASSOCIATION OF EZRIN AND FASCIN EXPRESSION IN BARRETT'S ESOPHAGUS WITH DIFFERENT GRADE OF NON-INVASIVE NEOPLASIA

2009 ◽  
Vol 41 ◽  
pp. S27
Author(s):  
N. De Bortoli ◽  
M.T. Locci ◽  
S. Maltinti ◽  
M. Pesce ◽  
E. Ciancia ◽  
...  
2013 ◽  
Vol 144 (5) ◽  
pp. S-684 ◽  
Author(s):  
Ajay Bansal ◽  
Xiaoman Hong ◽  
In-hee Lee ◽  
John House ◽  
Sharad C. Mathur ◽  
...  

2019 ◽  
Vol 156 (6) ◽  
pp. S-280
Author(s):  
Yonne Peters ◽  
Ruud W. Schrauwen ◽  
A.C. Tan ◽  
Sanne Bogers ◽  
Bart de Jong ◽  
...  

2019 ◽  
Author(s):  
Y Peters ◽  
RWM Schrauwen ◽  
AC Tan ◽  
SK Bogers ◽  
B de Jong ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-215-S-216
Author(s):  
Amit Bhatt ◽  
Mansour A. Parsi ◽  
Scott L. Gabbard ◽  
Arthi Kumaravel ◽  
David Grove ◽  
...  

2019 ◽  
Vol 156 (6) ◽  
pp. S-287-S-288
Author(s):  
Juan Reyes Genere ◽  
Kavel Visrodia ◽  
Liam Zakko ◽  
Bryan Linn ◽  
Magdalen A. Clemens ◽  
...  

2021 ◽  
Vol 9 (10) ◽  
pp. 2003
Author(s):  
Caitlin Guccione ◽  
Rena Yadlapati ◽  
Shailja Shah ◽  
Rob Knight ◽  
Kit Curtius

Esophageal adenocarcinoma (EAC) claims the lives of half of patients within the first year of diagnosis, and its incidence has rapidly increased since the 1970s despite extensive research into etiological factors. The changes in the microbiome within the distal esophagus in modern populations may help explain the growth in cases that other common EAC risk factors together cannot fully explain. The precursor to EAC is Barrett’s esophagus (BE), a metaplasia adapted to a reflux-mediated microenvironment that can be challenging to diagnose in patients who do not undergo endoscopic screening. Non-invasive procedures to detect microbial communities in saliva, oral swabs and brushings from the distal esophagus allow us to characterize taxonomic differences in bacterial population abundances within patients with BE versus controls, and may provide an alternative means of BE detection. Unique microbial communities have been identified across healthy esophagus, BE, and various stages of progression to EAC, but studies determining dynamic changes in these communities, including migration from proximal stomach and oral cavity niches, and their potential causal role in cancer formation are lacking. Helicobacter pylori is negatively associated with EAC, and the absence of this species has been implicated in the evolution of chromosomal instability, a main driver of EAC, but joint analyses of microbiome and host genomes are needed. Acknowledging technical challenges, future studies on the prediction of microbial dynamics and evolution within BE and the progression to EAC will require larger esophageal microbiome datasets, improved bioinformatics pipelines, and specialized mathematical models for analysis.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Ana C. P. Correia ◽  
Silvia Calpe ◽  
Nahid Mostafavi ◽  
Sanne Johanna Maria Hoefnagel ◽  
Maria del Carmen Sancho-Serra ◽  
...  

Abstract Barrett’s esophagus (BE) predisposes for the malignant condition of esophageal adenocarcinoma (EAC). Since BE patients have few or no symptoms, most of these patients are not identified and not included in surveillance programs. These BE patients are at risk of developing advanced-stage EAC. At present, non-invasive tests to identify BE patients from the general population are lacking. We and others showed that Bone Morphogenetic Protein 4 (BMP4), and other BMPs are upregulated in BE. We aimed to determine if circulating BMPs can be identified and used as blood biomarkers to identify BE patients at high risk in the general population. In this study, we could detect the different BMPs in the blood of 112 BE patients and 134 age- and sex-matched controls. Concentration levels of BMP2, BMP4, and BMP5 were elevated in BE patients, with BMP2 and BMP5 significantly increased. BMP5 remained significant after multivariate analysis and was associated with an increased risk for BE with an OR of 1.49 (p value 0.01). Per log (pg/mL) of BMP5, the odds of having BE increased by 50%. Future optimization and validation studies might be needed to prove its utility as a non-invasive method for the detection of BE in high-risk populations and screening programs.


2019 ◽  
Vol 4 ◽  
pp. 31-31
Author(s):  
Alok K. Shah ◽  
Virendra Joshi ◽  
Gunter Hartel ◽  
Andrew P. Barbour ◽  
Michelle M. Hill

Sign in / Sign up

Export Citation Format

Share Document